{"DataElement":{"publicId":"7247313","version":"1","preferredName":"Biospecimen Pathologic Examination CAP Grade","preferredDefinition":"The result of a pathological examination utilizing the College of American PathologistÂ’s (CAP) assessment scale.","longName":"6687939v1.0:6687929v1.0","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6687939","version":"1","preferredName":"Biospecimen Pathologic Examination","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","longName":"2859635v1.0:6687937v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2859635","version":"1","preferredName":"Biospecimen","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66832E51-39F3-1736-E040-BB89AD4349FB","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"UMLLOADER_TAVERNA","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6687937","version":"1","preferredName":"Pathologic Examination","preferredDefinition":"An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","longName":"C125006","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Examination","conceptCode":"C125006","definition":"An assessment of disease process to include cause, development, and/or structural and functional changes associated with the disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"86052F6F-B02C-4CBD-E053-F662850A23E9","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86052F6F-B03D-4CBD-E053-F662850A23E9","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeDescription":"3/18/22 mr Released per DCT and SME.   4/8/19 jk created for PCA Breast content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6687929","version":"1","preferredName":"CAP Grade","preferredDefinition":"A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine._A position on a scale of intensity or amount or quality.","longName":"6687929v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High","valueDescription":"High Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249018","version":"1","preferredName":"High Grade Ductal Breast Carcinoma In Situ","longName":"3249018","preferredDefinition":"A ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, High Grade","conceptCode":"C7949","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15EE-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86051438-3E83-4B6A-E053-F662850AF71C","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"Intermediate","valueDescription":"Intermediate Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249016","version":"1","preferredName":"Intermediate Grade Ductal Breast Carcinoma In Situ","longName":"3249016","preferredDefinition":"Ductal breast carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Intermediate Grade","conceptCode":"C9456","definition":"Breast ductal carcinoma in situ characterized by the presence of monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. Intraluminal necrosis is present in some ducts. Ducts that contain neoplastic cells with occasional nucleoli and coarse chromatin may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15C8-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86051438-3E98-4B6A-E053-F662850AF71C","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low Grade Ductal Breast Carcinoma In Situ","ValueMeaning":{"publicId":"3249014","version":"1","preferredName":"Low Grade Ductal Breast Carcinoma In Situ","longName":"3249014","preferredDefinition":"Ductal breast carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Low Grade","conceptCode":"C9457","definition":"Breast ductal carcinoma in situ characterized by the presence of small, monomorphic neoplastic cells that form cribriform, micropapillary, or solid patterns. The nuclei are uniform and mitotic figures are rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-15A2-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"86051438-3EAD-4B6A-E053-F662850AF71C","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"Data not available","valueDescription":"No Information Available","ValueMeaning":{"publicId":"2578438","version":"1","preferredName":"No Information Available","longName":"2578438","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF73-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D111728E-1E11-42E4-E053-4EBD850AD489","beginDate":"2021-11-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-18","modifiedBy":"ONEDATA","dateModified":"2021-11-18","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D111728E-1E1C-42E4-E053-4EBD850AD489","beginDate":"2021-11-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-11-18","modifiedBy":"ONEDATA","dateModified":"2021-11-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6687928","version":"1","preferredName":"College of American Pathologists Grade","preferredDefinition":"A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine.:A position on a scale of intensity or amount or quality.","longName":"C157719:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"College of American Pathologists","conceptCode":"C157719","definition":"A member-based physician that serves patients, pathologists, and the public by fostering and advocating best practices in pathology and laboratory medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86051438-3E51-4B6A-E053-F662850AF71C","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"86051438-3E62-4B6A-E053-F662850AF71C","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-08","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeDescription":"3/18/22 mr Released for breast per SME and DCT.   11/18/21 mr Increased max length to 20 and added 2 PVs for MCL PCA breast. 4/8/19 jk created for PCA Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"7035094","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001791","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"grade","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Grade","type":"Preferred Question Text","description":"Grade","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"breast_v1-2_08sep2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A35CE4F8-03A7-0F95-E053-F662850A2716","latestVersionIndicator":"Yes","beginDate":"2020-04-15","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-04-15","modifiedBy":"COLBERTM","dateModified":"2022-03-18","changeDescription":"3/18/22 mr Released per SME and DCT.   11/18/21 mr Updated VD, added CSI, alt def, ref doc per MCL PCA breast DCT. 4/15/20 jk created for PCA Breast.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}